rs150982499
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM3_SupportingPP4
This summary comes from the ClinGen Evidence Repository: The c.5039A>G (p.Lys1680Arg) variant in USH2A is a missense variant that replaces lysine with arginine at codon 1680. (Add gnomad information) The REVEL score for this variant is 0.252, which does not meet the threshold for PP3. This variant has been observed in the homozygous state in one individual with a clinical diagnosis of Usher syndrome (PMID:36909829), meeting PM3_Supporting. The phenotype observed is highly specific for Usher syndrome, meeting PP4. In summary, this variant meets criteria to be classified as uncertain significance for autosomal recessive Usher syndrome based on the ACMG/AMP criteria applied, as specified by the ClinGen Hearing Loss VCEP: PM3_Supporting, PP4. (ClinGen Hearing Loss VCEP specifications version 2; 5/21/2025) LINK:https://erepo.genome.network/evrepo/ui/classification/CA179559/MONDO:0019501/005
Frequency
Consequence
NM_206933.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| USH2A | NM_206933.4 | c.5039A>G | p.Lys1680Arg | missense_variant | Exon 25 of 72 | ENST00000307340.8 | NP_996816.3 | |
| USH2A-AS2 | NR_125992.1 | n.266-1896T>C | intron_variant | Intron 2 of 2 | ||||
| USH2A-AS2 | NR_125993.1 | n.137-1896T>C | intron_variant | Intron 1 of 1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| USH2A | ENST00000307340.8 | c.5039A>G | p.Lys1680Arg | missense_variant | Exon 25 of 72 | 1 | NM_206933.4 | ENSP00000305941.3 |
Frequencies
GnomAD3 genomes AF: 0.000217 AC: 33AN: 152204Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000128 AC: 32AN: 250788 AF XY: 0.0000885 show subpopulations
GnomAD4 exome AF: 0.0000951 AC: 139AN: 1461240Hom.: 0 Cov.: 30 AF XY: 0.0000894 AC XY: 65AN XY: 726916 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000217 AC: 33AN: 152322Hom.: 0 Cov.: 32 AF XY: 0.000255 AC XY: 19AN XY: 74484 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
- -
Classified as a variant of uncertain significance by the ClinGen Hearing Loss Expert Panel (ClinVar SCV001334309.1; Oza et al., 2018); In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 30311386) -
- -
Usher syndrome Uncertain:2
Clinical significance based on ACMG v2.0 -
The c.5039A>G (p.Lys1680Arg) variant in USH2A is a missense variant that replaces lysine with arginine at codon 1680. (Add gnomad information) The REVEL score for this variant is 0.252, which does not meet the threshold for PP3. This variant has been observed in the homozygous state in one individual with a clinical diagnosis of Usher syndrome (PMID: 36909829), meeting PM3_Supporting. The phenotype observed is highly specific for Usher syndrome, meeting PP4. In summary, this variant meets criteria to be classified as uncertain significance for autosomal recessive Usher syndrome based on the ACMG/AMP criteria applied, as specified by the ClinGen Hearing Loss VCEP: PM3_Supporting, PP4. (ClinGen Hearing Loss VCEP specifications version 2; 5/21/2025) -
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Benign. The p.Lys1680Arg va riant in USH2A has been previously reported by our laboratory in the heterozygou s state in 1 individual with hearing loss, but a variant affecting the remaining copy of the gene has not been identified. This variant has been identified in 2 0/34268 Latino chromosomes by the Genome Aggregation Database (gnomAD, http://gn omad.broadinstitute.org/; dbSNP rs150982499). Although this variant has been see n in the general population, its frequency is not high enough to rule out a path ogenic role. Computational prediction tools and conservation analyses suggest th at this variant may not impact the protein, though this information is not predi ctive enough to rule out pathogenicity. In summary, while the clinical significa nce of the p.Lys1680Arg variant is uncertain, available data suggest that it is more likely to be benign. -
Usher syndrome type 2A Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at